Newsroom | 5119 results

SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company, today announced it has been awarded a $2 million Phase 2 Small Business Innovation Research (SBIR) grant from the National Eye Institute (NEI) of the National Institutes of Health (NIH). The funding will advance the development of novel topical eye drops being investigated to control pediatric myopia and other refractive disorders. iVeena’s research is led by Sarah Molokhia, PhD, V...

RALEIGH, N.C.--(BUSINESS WIRE)--Lumata Health, the company focused on ending preventable blindness with continuous ophthalmic care for people facing chronic eye disease, today announced two new executive hires to propel the company into its next phase of expansion to meet the ophthalmic sector’s demand for its retinal disease treatment adherence solution. Annu Singh has been named Chief Technology Officer, leading the company's strategy and execution to build scalable, data-enabled, AI-assisted...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced the expansion of its leadership team with four senior appointments, including Robert Kim, M.D., MBA as Chief Medical Officer, Daniel Elgort, Ph.D. as Chief Data & Analytics Officer, Josh Buddle as Head of Clinical Network and Longitudinal Research, and Jessamyn Wead as Head of People. The company also announced an expansion of its Seri...

FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem cell (RPESC) therapies for dry age-related macular degeneration (dry AMD), today announced the publication of Phase 1/2a clinical trial results in a paper titled "Safety and Tolerability of RPE Stem Cell-derived RPE Transplantation in Patients with Dry Age-related Macular Degeneration: Low Dose Clinical Outcomes" in the journal Cell Stem C...

CLARKSBURG, Md.--(BUSINESS WIRE)--BrightFocus Foundation launches two national public service announcements encouraging eye exams to save sight from macular degeneration and glaucoma....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Holdings, Inc. (Nasdaq: HIND), a clinical-stage healthcare holding company, presented results from its preclinical studies investigating VT-1908 (the first topical formulation of mycophenolate) for treating uveitis at the recent Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics (1). Uveitis is the inflammation of a part of the eye, and is implicated in 30,000 new cases of legal blindness annually, in the United States...

AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases, today announced its launch with an initial $100 million in financing led by ARCH Venture Partners, Mubadala Capital and Monograph Capital. Ollin is assembling a robust pipeline of both clinical and late-stage preclinical programs, building upon validated biologies to better address unmet treat...

PÉKIN--(BUSINESS WIRE)--Le 3 septembre 2025, le « Symposium 2025 sur les nouvelles technologies de la vision périphérique rétinienne et la première conférence d'échange clinico-universitaire sur la VPR » s’est tenu à Hangzhou Chine. Organisé par Beijing NineStars Intelligent Medical Equipment Co. sous l'égide de l'Association chinoise de physiopathologie et de son Comité professionnel d'ophtalmologie, cet événement était centré sur l'application clinique de la technologie de mesure de la défoca...

BEIJING--(BUSINESS WIRE)--On September 3, 2025, the "2025 New Technology Symposium on Retinal Peripheral Vision and the First VPR Clinical Academic Exchange Conference" was held in Hangzhou, hosted by Chinese Association of Pathophysiology and Ophthalmology Professional Committee of Chinese Association of Pathophysiology, and organized by Beijing NineStars Intelligent Medical Equipment Co., Ltd. The conference focused on the launch and clinical application of wide-field retinal peripheral refra...

RALEIGH, N.C.--(BUSINESS WIRE)--iCare USA, a global innovator in eye care diagnostics, proudly unveils the launch of iCare ALTIUS™, a sleek cloud platform that’s set to disrupt how eye care professionals capture, manage, and share diagnostic images. Built for speed and designed for clarity, iCare ALTIUS changes the status quo of on-premise servers and clunky workflows. Hosted on a secure, HIPAA-compliant AWS backbone, this platform delivers instant access to diagnostic images and patient data—w...